Patents by Inventor Alan Xiang

Alan Xiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs of 5-amino-3-(3'-deoxy-b-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
    Publication number: 20080032999
    Abstract: The invention is directed to 5-amino-3-(3?-deoxy-?-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione prodrugs, whose metabolized parent compound has immunomodulatory activity. The invention also relates to the therapeutic use of such prodrugs and pharmaceutical compositions thereof in treating disease states associated with abnormal cell growth, such as cancer.
    Type: Application
    Filed: June 21, 2007
    Publication date: February 7, 2008
    Applicant: Anadys Pharmaceuticals, Inc.
    Inventors: Gregory Haley, Joseph Lennox, Alan Xiang, Stephen Webber
  • CARBONATE AND CARBAMATE PRODRUGS OF THIAZOLO[4,5-d]PYRIMIDINES
    Publication number: 20080020989
    Abstract: The invention is directed to carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidine compounds, whose metabolized parent compound has immunomodulatory activity. The invention also relates to the therapeutic use of such prodrugs and pharmaceutical compositions thereof in treating disease states associated with abnormal cell growth, such as cancer.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 24, 2008
    Applicant: Anadys Pharmaceuticals, Inc.
    Inventors: Gregory Haley, Joseph Lennox, Alan Xiang, Stephen Webber
  • 3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
    Publication number: 20060160830
    Abstract: The invention is directed to 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and pharmaceutical compositions containing them, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds and prodrugs.
    Type: Application
    Filed: December 16, 2005
    Publication date: July 20, 2006
    Applicant: Anadys Pharmaceuticals, Inc.
    Inventors: Stephen Webber, Gregory Haley, Joseph Lennox, Alan Xiang, Erik Rueden
  • 3-B-D-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof
    Publication number: 20050070556
    Abstract: The invention is directed to 3-?-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.
    Type: Application
    Filed: June 7, 2004
    Publication date: March 31, 2005
    Applicant: Anadys Pharmaceuticals, Inc.
    Inventors: Devron Averett, Stephen Webber, Joseph Lennox, Erik Rueden, David Clark, Alan Xiang